1. The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer
   Umar Wazir et al, 2013 CrossRef
2. Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs)
   Jia Zhong et al, 2017, Journal of Thoracic Oncology CrossRef
3. Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
   Josefine Bostner et al, 2017, Breast Cancer Res Treat CrossRef
4. Rheb phosphorylation is involved in p38-regulated/activated protein kinase-mediated tumor suppression in liver cancer
   MIN ZHENG et al, 2015 CrossRef
5. Milk—A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent Translation
   Bodo Melnik, 2015, IJMS CrossRef
6. Elevated Rictor expression is associated with tumor progression and poor prognosis in patients with gastric cancer
   Yuhai Bian et al, 2015, Biochemical and Biophysical Research Communications CrossRef
7. Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer
   Tarah J. Ballinger et al, 2018, Front. Oncol. CrossRef
8. Superhero Rictor promotes cellular differentiation of mouse embryonic stem cells
   Youming Zhu et al, 2018, Cell Death Differ CrossRef
9. miR-503 is down-regulated in osteosarcoma and suppressed MG63 proliferation and invasion by targeting VEGFA/Rictor
   Tu Lv et al, 2018, CBM CrossRef
10. mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy.
    Tian Tian et al, 2019, Int J Mol Sci CrossRef
11. mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis
    Meghan M. Morrison et al, 2015, PLoS Genet CrossRef
12. Therapeutic implication of mTORC2 in oral squamous cell carcinoma.
    Tomofumi Naruse et al, 0 CrossRef
13. MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability
    Francesca Mancini et al, 2017, Mol Cancer CrossRef
14. Overexpression of RHEB is associated with metastasis and poor prognosis in hepatocellular carcinoma
    Fuchen Liu et al, 2018, Oncol Lett CrossRef
15. An Immunohistochemical Study of the PTEN/AKT Pathway Involvement in Canine and Feline Mammary Tumors
    Pietro Asproni et al, 2021, Animals CrossRef
16. Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer
    Say Li Kong et al, 2021, Front. Oncol. CrossRef
17. Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma
    Zheng Yao et al, 2021, BioMed Research International CrossRef
18. Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
    Chenxing Wang et al, 2022, BMC Cancer CrossRef
19. Identifying Key Lysosome-Related Genes Associated with Drug-Resistant Breast Cancer Using Computational and Systems Biology Approach
    Aref Shiralipour et al, 2022, Iran J Pharm Res CrossRef
20. Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy
    Abdelhakim Bouyahya et al, 2022, Cancers CrossRef
21. NUCB2/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway
    Siyi Ning et al, 2023, J Transl Med CrossRef
22. The Molecular and Genetic Interactions between Obesity and Breast Cancer Risk
    Ghada M. A. Ajabnoor, 2023, Medicina CrossRef
23. A rare ginsenoside compound K (CK) induces apoptosis for breast cancer cells
    Seun Eui Kim et al, 2023, J Anim Reprod Biotechnol CrossRef
24. Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing
    Dániel Sztankovics et al, 2023, Sci Rep CrossRef
25. Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling
    Mostafizur Rahman et al, 2024, IJMS CrossRef
26. Rictor—A Mediator of Progression and Metastasis in Lung Cancer
    Fatime Szalai et al, 2024, Cancers CrossRef
27. mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies
    Dániel Sztankovics et al, 2024, Pathol. Oncol. Res. CrossRef
28. The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advances
    Ayda Baghery Saghchy Khorasani et al, 2024, Cell Biochemistry & Function CrossRef